Quarterly report · Q3
4188.TEDINET S100Q5UL
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.41T | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.14T | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.90T | 2021-04-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.02T | 2021-10-01 → 2021-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥48.6bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | −¥69.7bn | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥218.2bn | 2021-04-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥65.1bn | 2021-10-01 → 2021-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥39.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥82.8bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥208.2bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.0bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥17.0bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥56.9bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥122.1bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥37.0bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥44.8bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | −¥46.7bn | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥147.3bn | 2021-04-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥45.3bn | 2021-10-01 → 2021-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥5.86T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.57T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.46T | at 2021-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.96T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.73T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.90T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.71T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.57T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.50T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.35T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥257.0bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥259.3bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥174.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥248.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥174.4bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥140.6bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥8.8bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥200.6bn | 2021-04-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥11.99 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-40.02 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥85.95 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥26.01 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥11.55 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-40.02 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥79.06 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥23.93 | 2021-10-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 25.5% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.7% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥309.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥162.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥147.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥11.4bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥230.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥230.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥9.7bn |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.14T |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.10T |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥37.2bn |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥19.3bn |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥332.0bn |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥331.6bn |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥416m |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥18.5bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥873.0bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥866.4bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥6.7bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥84.3bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥983.5bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥944.5bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥38.9bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥54.1bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥3.33T |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥3.24T |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥83.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥176.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥3.64T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥3.41T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥230.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥187.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-12-31 | ¥279.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥130.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥148.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥10.3bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥223.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥223.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥10.8bn |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥953.7bn |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥921.8bn |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥31.9bn |
| jpcrp040300-q3r_E00808-000Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥83.5bn |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥312.4bn |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥312.1bn |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥247m |
| jpcrp040300-q3r_E00808-000Health Carereportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥691.5bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥686.6bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥5.0bn |
| jpcrp040300-q3r_E00808-000Industrial Gasesreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥73.9bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥887.4bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥848.9bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥38.5bn |
| jpcrp040300-q3r_E00808-000Performance Productsreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥57.5bn |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥2.84T |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥2.77T |
| —segment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥75.6bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | ¥219.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥3.12T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥2.90T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥223.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥229.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 925
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYTDDuration | -174432000000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -128781000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YTDDuration | -200553000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | CurrentYTDDuration | 8803000000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | -336283000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 259300000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 257047000000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 245789000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1506288107 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 1506288107 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 1506288107 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 1506288107 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 81880100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 175100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 14214776 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1421477600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 2755307 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 1506288107 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 14214776 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 81880100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 81880100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0544 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row2Member | 2400 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row2Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row2Member | 2400 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row2Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row3Member | 2800 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row3Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row3Member | 2800 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row3Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row4Member | 169900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row4Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row4Member | 169900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row4Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 82055200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 82055200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0545 | |
| Number of male directors and other officers | FilingDateInstant | 16 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.158 | |
| Revenue IFRS | Prior1YTDDuration | 2900294000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 3406165000000 | JPY |
| Cost of sales IFRS | Prior1YTDDuration | 2060438000000 | JPY |
| Cost of sales IFRS | CurrentYTDDuration | 2550311000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |